Pharmacy Practice Model Initiative Demonstration Grants

Application Submission Materials Available: July 17, 2014
Letter of Intent Deadline: September 26, 2014



Grant Program Description
The ASHP Foundation is offering a research grant program that supports demonstration projects related to the ASHP/ASHP Foundation Pharmacy Practice Model Initiative (PPMI). The overarching goal of the PPMI is to increase pharmacist participation on patient care teams as the professional who is responsible and accountable for patients’ medication-related outcomes while delegating all medication distribution functions that do not require clinical judgment to qualified pharmacy technicians and technology.

The proposed practice-based research must be consistent with the vision, mission and strategic priorities of the ASHP Foundation. The PPMI is driven by a set of assumptions, beliefs and recommendations from the November 2010 ASHP/ASHP Foundation PPMI Summit.

The following research priorities have been established by the ASHP Foundation for the PPMI Demonstration Grants Program:

Pharmacists’ Roles
The following are priority areas related to the pharmacist’s role in advancing pharmacy practice models as the interprofessional team member who is responsible and accountable for patients’ medication-related outcomes:

• Comparative evaluations of the impact of inpatient pharmacist-provided core clinical services on patients’ therapeutic and safety outcomes. (See the core clinical services included in the following recommendations from the PPMI Summit: B7-9, B13-16, B20-21, B23a-o, B24a-b, B25b.)
• Comparative evaluations of the impact of hospital/health-system-based outpatient pharmacist-provided core clinical services on patients’ therapeutic and safety outcomes. (See the core clinical services included in the following recommendations from the PPMI Summit: B7-9, B13-16, B20-21, B23a-o, B24a-b, B25b.)
• Evaluations of the economic benefits of hospital, health-system, and ambulatory pharmacist-provided core clinical services. (See the core clinical services included in the following recommendations from the PPMI Summit: B7-9, B13-16, B20-21, B23a-o, B24a-b, B25b. This study must include an element that demonstrates efficient methods to track and analyze pharmacists’ clinical interventions.)

Pharmacy Technicians and Technology
The following are priority areas related to the roles of pharmacy technicians and technology in advancing pharmacy practice models:

• Evaluations of delegation of all distributive functions that do not require clinical judgment to pharmacy technicians and technology. (See the pharmacy technician-related assumptions, beliefs and recommendations from the PPMI Summit.)
• Evaluations of the use of pharmacy technicians to perform clinical support functions. (See the pharmacy technician-related assumptions, beliefs and recommendations from the PPMI Summit.)
• Evaluations of the impact of accredited technician training programs and Pharmacy Technician Certification Board (PTCB) certification on technician effectiveness.
• Evaluations of the use of existing technology systems in supporting advancement of pharmacy practice models. (See the pharmacy technology-related assumptions, beliefs and recommendations from the PPMI Summit.)

Pharmacist Education
The following is the priority area related to the role of pharmacist education in advancing pharmacy practice models:

• Evaluations of innovative residency program models that result in expansion of the number of residency-trained pharmacists who can participate as the interdisciplinary team members who are responsible and accountable for patients’ medication-related outcomes.

Applications for this research grant program should emphasize:

1. Measurable objectives that relate to practice-based research that focuses on advancing pharmacy practice models.
2. Rigorous research methods that support the study objectives.
3. A description of the impact that the results of the project will have on advancing pharmacy practice models.
4. A description of the potential to generalize findings to other health care facilities.
5. Interprofessional collaboration.
6. An organized plan for prudent use of grant funds.

Preference will be given to research projects with the potential to yield strong scientific evidence that can be applied to practice.


Eligibility

The proposed research must involve demonstration projects focused on the PPMI research priorities listed above. The principal investigator must be a licensed pharmacist, and multidisciplinary research teams are strongly encouraged. The principal investigator MUST have a strong research track record as evidenced by a history of publication of original research in peer-reviewed biomedical journals and receipt of extramural grant funding. Consideration should be given to allocating a portion of the budget to support biostatistics consultation.

The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval, or exemption from review, has been received.

The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research that was amended in October 2001. The research must comply with the NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects.

The study timeline should not exceed 24 months from project initiation.

 
Funding Information
Up to two $75,000 grants will be awarded.

Grants will be awarded to provide funding for specific practice-based research related to advancing pharmacy practice models and are not intended for long-term support of research programs.  Facilities and administrative cost rates that do not exceed 8% of the total requested budget are allowed.

Letter of Intent Submission Process and Selection Criteria
All interested applicants are required to submit a Letter of Intent to the ASHP Foundation by September 26, 2014. This Letter of Intent must be limited to a maximum of two pages (using 11-point font or larger, 8.5 x 11-inch paper, 1-inch margins, single spacing and single-sided pages) and should concisely describe the study’s specific aims and hypothesis, rationale and significance, innovation and approach. Headings should be provided for each of these sections. View the scale used to score the Letters of Intent.


Additional Review Considerations
In the written review and during the review call, reviewers will also address protection of human subjects, inclusiveness, patient privacy and safety protections, and budget/budget justification.

Based on the results of external peer review of Letters of Intent, applicants will be invited to submit a full grant application to the ASHP Foundation. Prior to submission of a full application, applicants will be required to participate in a webinar that describes the grant program requirements and expectations.

The full applications for the grant will be evaluated using the selection criteria listed below:

Overall Funding Priority Score = ________ (1-9)
Using the following rating scale, reviewers will provide an overall priority score to reflect their overall assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved. This score represents the reviewers overall assessment of the application and is not based only on the criteria-based score. View the scale used to score the applications.

Criteria Based Score = ________ (0-100)
Using the following criteria, reviewers should provide an overall score to reflect their assessment of the study: rationale; objectives; significance and innovation; investigators and environment; study methods; and scope and timeline.

• Specific Aims and Hypothesis (20 points maximum)
• Rationale and Significance (10 points maximum)
• Innovation (10 points maximum)
• Investigators and Environment (15 point maximum)
• Approach (40 points maximum)
• Scope and Timeline (5 points maximum)


Submission Materials
Please submit letters of intent using the electronic submission process, which you can access below:

Complete the online Letter of Intent
Read the Application Instructions
Watch a recording of the August 20th "How to Submit a Successful Application" webinar. (Please note that download may take approximately 30 seconds.)
Download a PDF of the webinar slides.


Deadlines
• "How to Submit a Successful Application" webinar: August 20, 2014 (register here)
• Letter of Intent Deadline: September 26, 2014


Selected Grantees
Learn more about the selected grantees.

From: 
Email:  
To: 
Email:  
Subject: 
Message: